참고문헌 (49)

1. World J. Gastroenterol Crew 12 354 2006 10.3748/wjg.v12.i3.354 Epidemiology of gastric cancer 

   상세보기

2. Surgery Maehara 110 820 1991 Pertinent risk factors and gastric carcinoma with synchronous peritoneal dissemination or liver metastasis 

3. Surg. Oncol Moriguchi 1 341 1992 10.1016/0960-7404(92)90034-I Risk factors which predict pattern of recurrence after curative surgery for patients with advanced gastric cancer 

   상세보기

4. Science Bottaro 251 802 1991 10.1126/science.1846706 Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product 

   상세보기

5. Cancer Lett Christensen 225 1 2005 10.1016/j.canlet.2004.09.044 c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention 

   상세보기

6. Oncogene Di Renzo 6 1997 1991 Expression of the Met/HGF receptor in normal and neoplastic human tissues 

   상세보기

7. Nat. Rev. Drug Discov Comoglio 7 504 2008 10.1038/nrd2530 Drug development of MET inhibitors: targeting oncogene addiction and expedience 

   상세보기

8. Expert Opin. Investig. Drugs Liu 17 997 2008 10.1517/13543784.17.7.997 Targeting the c-MET signaling pathway for cancer therapy 

   상세보기

9. Cancer Lett Zeng 265 258 2008 10.1016/j.canlet.2008.02.049 c-Met gene amplification is associated with advanced stage colorectal cancer and liver metastases 

   상세보기

10. Cancer Res Seiwert 69 3021 2009 10.1158/0008-5472.CAN-08-2881 The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma 

    상세보기

11. Clin. Cancer Res Knowles 15 3740 2009 10.1158/1078-0432.CCR-08-3252 HGF and c-Met participate in paracrine tumorigenic pathways in head and neck squamous cell cancer 

    상세보기

12. Int. J. Cancer Toiyama 125 1657 2009 10.1002/ijc.24554 Serum hepatocyte growth factor as a prognostic marker for stage II or III colorectal cancer patients 

    상세보기

13. Cancer Sci Inoue 95 803 2004 10.1111/j.1349-7006.2004.tb02185.x Activation of c-Met (hepatocyte growth factor receptor) in human gastric cancer tissue 

    상세보기

14. J. Surg. Res Wang 120 242 2004 10.1016/j.jss.2003.12.018 Alterations of APC, c-met, and p53 genes in tumor tissue and serum of patients with gastric cancers 

    상세보기

15. Cell Corson 130 769 2007 10.1016/j.cell.2007.08.021 Molecular understanding and modern application of traditional medicines: triumphs and trials 

    상세보기

16. The Medicinal Plant of Korea Bang 139 1999 

17. Crit. Rev. Food Sci. Nutr Price 26 27 1987 10.1080/10408398709527461 The chemistry and biological significance of saponins in foods and feedingstuffs 

    상세보기

18. J. Agric. Food Chem Taylor 48 5206 2000 10.1021/jf000467t Microdetermination of diosgenin from fenugreek ( Trigonella foenum-graecum ) seeds 

    상세보기

19. Phytochemistry Vincken 68 275 2007 10.1016/j.phytochem.2006.10.008 Saponins, classification and occurrence in the plant kingdom 

    상세보기

20. Proc. Natl Acad. Sci. USA Haridas 98 5821 2001 10.1073/pnas.101619098 Avicins: triterpenoid saponins from Acacia victoriae (Bentham) induce apoptosis by mitochondrial perturbation 

    상세보기

21. Cancer Res Mujoo 61 5486 2001 Triterpenoid saponins from Acacia victoriae (Bentham) decrease tumor cell proliferation and induce apoptosis 

    상세보기

22. Cancer Res Qian 69 8009 2009 10.1158/0008-5472.CAN-08-4889 Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases 

    상세보기

23. Proteins Diller 43 113 2001 10.1002/1097-0134(20010501)43:2<113::AID-PROT1023>3.0.CO;2-T High throughput docking for library design and library prioritization 

    상세보기

24. Oncogene Recio 21 1000 2002 10.1038/sj.onc.1205150 Hepatocyte growth factor/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1 

    상세보기

25. Oncogene Zhang 21 217 2002 10.1038/sj.onc.1205004 Requirement of Stat3 signaling for HGF/SF-Met mediated tumorigenesis 

    상세보기

26. Cell Ponzetto 77 261 1994 10.1016/0092-8674(94)90318-2 A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family 

    상세보기

27. Curr. Opin. Pharmacol Yap 8 393 2008 10.1016/j.coph.2008.08.004 Targeting the PI3K-AKT-mTOR pathway: progress, pitfalls, and promises 

    상세보기

28. Proc. Natl Acad. Sci. USA Huang 95 7987 1998 10.1073/pnas.95.14.7987 Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway 

    상세보기

29. Nat. Rev. Mol. Cell Biol Birchmeier 4 915 2003 10.1038/nrm1261 Met, metastasis, motility and more 

    상세보기

30. Proc. Natl Acad. Sci. U S A Zhang 100 12718 2003 10.1073/pnas.2135113100 Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation 

    상세보기

31. Mol. Carcinog Zykova 47 797 2008 10.1002/mc.20437 Resveratrol directly targets COX-2 to inhibit carcinogenesis 

    상세보기

32. Cancer Res Ermakova 66 9260 2006 10.1158/0008-5472.CAN-06-1586 (？ 

    상세보기

33. Cancer Res Jeong 69 5584 2009 10.1158/0008-5472.CAN-09-0491 [6]-Gingerol suppresses colon cancer growth by targeting leukotriene A4 hydrolase 

    상세보기

34. Carcinogenesis Jung 31 911 2010 10.1093/carcin/bgp221 Myricetin inhibits UVB-induced angiogenesis by regulating PI-3 kinase in vivo 

    상세보기

35. Nat. Chem. Biol Liu 2 358 2006 10.1038/nchembio799 Rational design of inhibitors that bind to inactive kinase conformations 

    상세보기

36. Curr. Opin. Oncol Jabbour 18 578 2006 10.1097/01.cco.0000245314.97638.d3 Novel tyrosine kinase inhibitors in chronic myelogenous leukemia 

    상세보기

37. Nat. Rev. Cancer Zhang 9 28 2009 10.1038/nrc2559 Targeting cancer with small molecule kinase inhibitors 

    상세보기

38. J. Med. Chem Kufareva 51 7921 2008 10.1021/jm8010299 Type-II kinase inhibitor docking, screening, and profiling using modified structures of active kinase states 

    상세보기

39. Nat. Chem. Biol Simard 5 394 2009 10.1038/nchembio.162 A new screening assay for allosteric inhibitors of cSrc 

    상세보기

40. Mol. Cancer Ther Okamoto 11 1557 2012 10.1158/1535-7163.MCT-11-0934 Antitumor action of the MET tyrosine kinase inhibitor crizotinib (PF-02341066) in gastric cancer positive for MET amplification 

    상세보기

41. Trends Mol. Med Corso 11 284 2005 10.1016/j.molmed.2005.04.005 Cancer therapy: can the challenge be MET? 

    상세보기

42. Arch. Biochem. Biophys Wang 526 38 2012 10.1016/j.abb.2012.07.003 Inhibition of c-Met activation sensitizes osteosarcoma cells to cisplatin via suppression of the PI3K-Akt signaling 

    상세보기

43. Carcinogenesis Nam 31 1531 2010 10.1093/carcin/bgq133 The PI3K-Akt mediates oncogenic Met-induced centrosome amplification and chromosome instability 

    상세보기

44. Leukemia Derksen 17 764 2003 10.1038/sj.leu.2402875 The hepatocyte growth factor/Met pathway controls proliferation and apoptosis in multiple myeloma 

    상세보기

45. Proc. Natl Acad. Sci. USA Xiao 98 247 2001 10.1073/pnas.98.1.247 Anti-apoptotic signaling by hepatocyte growth factor/Met via the phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways 

    상세보기

46. Proc. Natl Acad. Sci. USA Ponzo 106 12903 2009 10.1073/pnas.0810402106 Met induces mammary tumors with diverse histologies and is associated with poor outcome and human basal breast cancer 

    상세보기

47. Cancer Res Zou 67 4408 2007 10.1158/0008-5472.CAN-06-4443 An orally available small-molecule inhibitor of c-Met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms 

    상세보기

48. J. Gene Med Heideman 6 317 2004 10.1002/jgm.523 Suppression of tumor growth, invasion and angiogenesis of human gastric cancer by adenovirus-mediated expression of NK4 

    상세보기

49. Am. J. Pathol Xin 158 1111 2001 10.1016/S0002-9440(10)64058-8 Hepatocyte growth factor enhances vascular endothelial growth factor-induced angiogenesis in vitro and in vivo 

    상세보기